March 11, 2025 - 13:12

Khalil Mack has officially signed a one-year deal worth $18 million to remain with the Los Angeles Chargers for the upcoming 2025 season. As he enters his 12th year in the NFL, the seasoned linebacker is determined to achieve what has eluded him throughout his illustrious career: a playoff victory. Despite being widely recognized as one of the league's premier defensive players, Mack has yet to experience the thrill of winning in the postseason.
Mack's commitment to the Chargers reflects his desire to not only contribute to the team's success but also to solidify his legacy in the league. With a wealth of experience and a relentless drive, he aims to help lead the Chargers to the playoffs and beyond. The team has high hopes for the upcoming season, and Mack's presence on the field is expected to play a pivotal role in their quest for a championship. As the season approaches, fans are eager to see if Mack can finally turn his "unfinished business" into a victorious reality.
July 10, 2026 - 04:47
Baker Hughes CEO: Continued business tailwinds with the need for power generation and LNGLorenzo Simonelli, the chief executive of Baker Hughes, appeared on `Power Lunch` to discuss the company`s outlook, pointing to sustained business tailwinds fueled by the growing need for power...
July 9, 2026 - 04:31
The Software Business Model Is Running Out of Time—and So Are Software StocksThe era of easy money for traditional software companies is coming to an end, and Wall Street is starting to panic. According to analysts at Stifel, the old ways of selling software-think long-term...
July 8, 2026 - 00:07
George E. Johnson Sr., founder of a pioneering Black hair care business, dies at 99George E. Johnson Sr., the visionary entrepreneur who built a multimillion dollar hair care empire and broke racial barriers on Wall Street, has died. He was 99. His family confirmed he passed away...
July 7, 2026 - 02:47
Medtronic recalls heart valve delivery system due to safety riskMedtronic has announced a recall for a specific heart valve delivery system, citing a safety risk that could affect patients. The recall involves the company`s Evolut FX and Evolut PRO+ delivery...